Bioqual (BIOQ) Stock Price, News & Analysis

Company Overview

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.

Key Stats

• Today's Range: $70.00 to $70.00
• 50-Day Range: $70.00 to $72.50
• 52-Week Range: $59.00 to $80.00
• Volume: N/A
• Average Volume: 317 shs
• Market Capitalization: $63 million
• P/E Ratio: 65.42
• Dividend Yield: 0.71%
• Price Target: N/A
• Consensus Rating: N/A

BIOQ Stock Analysis - Frequently Asked Questions

How have BIOQ shares performed this year?

Bioqual's stock was trading at $64.00 at the beginning of 2024. Since then, BIOQ shares have increased by 9.4% and is now trading at $70.00.
View the best growth stocks for 2024 here.

How do I buy shares of Bioqual?

Shares of BIOQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Today: 9/18/2024
• Fiscal Year End: 5/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Commercial physical research
• Sub-Industry: Business Services
• Current Symbol: OTCMKTS:BIOQ
• CUSIP: 09065J101
• CIK: 719711
• Web: www.bioqual.com
• Phone: (240) 404-7654
• Fax: N/A
• Employees: 114
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): $1.07
• Trailing P/E Ratio: 65.42
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $840,000.00
• Net Margins: 1.51%
• Pretax Margin: 1.98%
• Return on Equity: 2.47%
• Return on Assets: 1.57%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 4.22
• Quick Ratio: 4.22

Sales & Book Value

• Annual Sales: $62.66 million
• Price / Sales: 1.01
• Cash Flow: $15.02 per share
• Price / Cash Flow: 4.66
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 900,000
• Free Float: N/A
• Market Cap: $63 million
• Optionable: Not Optionable
• Beta: -0.31